SCHEMBL16624918

SCHEMBL16624918

COc1ccc(C(=O)CC(CC(=O)OCCC(C)C)c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.64
ALDH1A1 P00352 7/20 0.47
ATM Q13315 1/20 0.45
MAPK1 P28482 1/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPT P10636 3/20 0.44
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
FNTA P49354 1/20 0.43
FNTB P49356 1/20 0.43
GAA P10253 1/20 0.42
HSD11B1 P28845 1/20 0.41
THRB P10828 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624895 0.90 L3MBTL1 (0.55) L3MBTL1ALDH1A1ATMMAPK1NPC1
SCHEMBL19071336 0.89 L3MBTL1 (0.49) L3MBTL1ALDH1A1MAPK1NPC1RAB9A
SCHEMBL16624920 0.88 L3MBTL1 (0.47) L3MBTL1ALDH1A1ATMMAPK1NPC1
SCHEMBL19071153 0.86 F2 (0.48) L3MBTL1ALDH1A1ATMMAPK1NPC1
SCHEMBL16624892 0.85 L3MBTL1 (0.71) L3MBTL1ALDH1A1ATMNPC1RAB9A
SCHEMBL16624894 0.85 L3MBTL1 (0.63) L3MBTL1ALDH1A1ATMNPC1RAB9A
SCHEMBL16624905 0.85 L3MBTL1 (0.54) L3MBTL1ALDH1A1ATMNPC1RAB9A
SCHEMBL16624900 0.84 L3MBTL1 (0.76) L3MBTL1ALDH1A1ATMNPC1RAB9A
SCHEMBL16624903 0.81 MAPT (0.45) L3MBTL1ALDH1A1MAPK1NPC1RAB9A
SCHEMBL19071295 0.81 L3MBTL1 (0.81) L3MBTL1ALDH1A1ATMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864284-B1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO KGAA (DE) 2017-07-05 EP disclosed
US-9458081-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2016-10-04 US disclosed
US-9458081-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2016-10-04 US disclosed
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-04-09 US disclosed
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES TRPA1, PSAP, CRY1 L3MBTL1 1799/4885ALDH1A1 236/4885ATM 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.